Clinical Trials Browser

OTHER × Advanced Biliary Tract Cancer × Clear all

NCT04781192 2026-01-23

The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers

Phase 1/2 Active not recruiting

Gastrointestinal

Advanced Biliary Tract Cancer

NCT06988592 2025-05-29

BTC-IM-1

Gastrointestinal

Advanced Biliary Tract Cancer

NCT06708858 2024-11-27

Phase Ⅱ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract Cancer

Phase 2 Recruiting

Gastrointestinal

Advanced Biliary Tract Cancer

NCT04727996 2024-04-19

BTC-BGB

Phase 2 Active not recruiting

Gastrointestinal

Advanced Biliary Tract Cancer

NCT05820906 2023-12-06

Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

NCT05823987 2023-06-27

OPTIONS-05

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

NCT04217954 2023-06-23

HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC

Phase 2 Completed

Gastrointestinal

Advanced Biliary Tract Cancer

NCT05781074 2023-03-24

CASTLE-08

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

NCT05410197 2022-10-12

Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN)

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

NCT04027764 2019-07-22

Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

NCT03358849 2019-01-16

Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract Cancer

Phase 1 Completed

Gastrointestinal

Advanced Biliary Tract Cancer